铁死亡在肿瘤相关的研究进展
Research Progress of Ferroptosis in Tumor-Related Studies
DOI: 10.12677/acm.2025.1551597, PDF,    科研立项经费支持
作者: 刘春东, 雷小楠, 樊清睿:西安医学院研究生处,陕西 西安;杜 春*:陕西省人民医院泌尿外科,陕西 西安
关键词: 铁死亡纳米载体mitoROSmiR-101-3pAscACSL4GPX4Ferroptosis Nanocarrier mitoROS miR-101-3p Asc ACSL4 GPX4
摘要: 铁是几乎所有生物系统中必不可少的金属。然而,细胞内的铁含量需要严格调节,因为过量的铁会随着ROS的产生而产生破坏性影响,铁死亡是一种新型的由铁依赖性脂质过氧化作用引起的氧化调节细胞死亡。铁死亡涉及遗传、代谢和蛋白质的调节、触发和执行机制,在很大程度上与其他形式的受调节细胞死亡不重叠。脂质代谢对于肿瘤的增殖以及侵袭、转染都具有很重要的作用,例如细胞膜层面的高水平膜脂质与肿瘤细胞抵御活性氧(ROS)的损伤密切相关,由于高饱和度的膜脂对于氧化反应的刺激不敏感这为肿瘤细胞无形中提供了保护作用。目前主流的肿瘤化疗采用诱导凋亡的方式杀死或抑制肿瘤细胞。然而,越来越明显地是,肿瘤细胞可能对这些依赖凋亡的抗肿瘤方式表现出内在或获得性抵抗,从而大大增加了治疗失败和治疗后复发的风险。对于肿瘤而言,越来越多研究表明,在肿瘤组织中,铁死亡被显著抑制,导致了肿瘤不受控制地转移以及侵袭,这也为调节靶向肿瘤细胞的死亡对于肿瘤的免疫治疗提供了一种新的治疗方式以及为其他以异常细胞增生的疾病提供新的治疗思路。有趣的是,治疗耐药的癌细胞,特别是那些间充质状态和易于转移的癌细胞,非常容易发生铁死亡。目前许多研究证实:铁死亡与肿瘤存在密切的联系,并且涉及一系列机制,并且铁死亡还可以根除一些凋亡不敏感的肿瘤细胞,激活铁死亡途径可能是克服传统癌症治疗耐药机制的潜在策略。故此铁死亡的相关研究进展对于肿瘤的治疗而言具有重要的意义。
Abstract: Iron is an essential metal in almost all biological systems. However, the intracellular iron content needs to be strictly regulated because excessive iron can have destructive effects along with the generation of reactive oxygen species (ROS). Ferroptosis is a novel type of oxidative regulated cell death caused by iron-dependent lipid peroxidation. Ferroptosis involves the regulatory, triggering and execution mechanisms of genetics, metabolism and proteins, and largely does not overlap with other forms of regulated cell death. Lipid metabolism plays a very important role in the proliferation. High levels of membrane lipids at the cellular membrane level are highly correlated with the ability of tumor cells to avoid damage from reactive oxygen species (ROS). Because membrane lipids with high saturation are insensitive to the stimuli of oxidation reactions, they provide an invisible protective effect for tumor cells. Currently, the mainstream tumor chemotherapy uses the method of inducing apoptosis to kill or inhibit tumor cells. However, it is becoming increasingly evident that tumor cells may exhibit intrinsic or acquired resistance to these apoptosis-dependent anti-tumor approaches, which greatly increases the risk of treatment failure and recurrence after treatment. For tumors, more and more studies have shown that in tumor tissues, ferroptosis is significantly inhibited, leading to uncontrolled metastasis and invasion of tumors. This also provides a new treatment approach for tumor immunotherapy by regulating the death of targeted tumor cells, and offers new treatment ideas for other diseases characterized by abnormal cell proliferation. Interestingly, cancer cells resistant to treatment, especially those in a mesenchymal state and prone to metastasis, are highly susceptible to ferroptosis. Currently, many studies have confirmed that there is a close relationship between ferroptosis and tumors, involving a series of mechanisms. Moreover, ferroptosis can also eradicate some tumor cells that are insensitive to apoptosis. Activating the ferroptosis pathway may be a potential strategy to overcome the resistance mechanisms of traditional cancer treatments. Therefore, the relevant research progress of ferroptosis is of great significance for the treatment of tumors.
文章引用:刘春东, 雷小楠, 樊清睿, 杜春. 铁死亡在肿瘤相关的研究进展[J]. 临床医学进展, 2025, 15(5): 2099-2109. https://doi.org/10.12677/acm.2025.1551597

参考文献

[1] Dan Dunn, J., Alvarez, L.A., Zhang, X. and Soldati, T. (2015) Reactive Oxygen Species and Mitochondria: A Nexus of Cellular Homeostasis. Redox Biology, 6, 472-485. [Google Scholar] [CrossRef] [PubMed]
[2] Jhurry, N.D., Chakrabarti, M., McCormick, S.P., Holmes-Hampton, G.P. and Lindahl, P.A. (2012) Biophysical Investigation of the Ironome of Human Jurkat Cells and Mitochondria. Biochemistry, 51, 5276-5284. [Google Scholar] [CrossRef] [PubMed]
[3] Rauen, U., Springer, A., Weisheit, D., Petrat, F., Korth, H., de Groot, H., et al. (2007) Assessment of Chelatable Mitochondrial Iron by Using Mitochondrion‐Selective Fluorescent Iron Indicators with Different Iron‐Binding Affinities. ChemBioChem, 8, 341-352. [Google Scholar] [CrossRef] [PubMed]
[4] Battaglia, A.M., Chirillo, R., Aversa, I., Sacco, A., Costanzo, F. and Biamonte, F. (2020) Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death. Cells, 9, Article No. 1505. [Google Scholar] [CrossRef] [PubMed]
[5] Galluzzi, L., Vitale, I., Aaronson, S.A., Abrams, J.M., Adam, D., Agostinis, P., et al. (2018) Molecular Mechanisms of Cell Death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death & Differentiation, 25, 486-541. [Google Scholar] [CrossRef] [PubMed]
[6] Tang, D., Kang, R., Berghe, T.V., Vandenabeele, P. and Kroemer, G. (2019) The Molecular Machinery of Regulated Cell Death. Cell Research, 29, 347-364. [Google Scholar] [CrossRef] [PubMed]
[7] Liu, M., Kong, X., Yao, Y., Wang, X., Yang, W., Wu, H., et al. (2022) The Critical Role and Molecular Mechanisms of Ferroptosis in Antioxidant Systems: A Narrative Review. Annals of Translational Medicine, 10, 368-368. [Google Scholar] [CrossRef] [PubMed]
[8] Sabharwal, S.S. and Schumacker, P.T. (2014) Mitochondrial ROS in Cancer: Initiators, Amplifiers or an Achilles’ Heel? Nature Reviews Cancer, 14, 709-721. [Google Scholar] [CrossRef] [PubMed]
[9] Barrera, G., Gentile, F., Pizzimenti, S., Canuto, R., Daga, M., Arcaro, A., et al. (2016) Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products. Antioxidants, 5, Article No. 7. [Google Scholar] [CrossRef] [PubMed]
[10] Hou, J., Jiang, C., Wen, X., Li, C., Xiong, S., Yue, T., et al. (2022) ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics. Frontiers in Pharmacology, 13, Article ID: 949863. [Google Scholar] [CrossRef] [PubMed]
[11] Doll, S., Proneth, B., Tyurina, Y.Y., Panzilius, E., Kobayashi, S., Ingold, I., et al. (2016) ACSL4 Dictates Ferroptosis Sensitivity by Shaping Cellular Lipid Composition. Nature Chemical Biology, 13, 91-98. [Google Scholar] [CrossRef] [PubMed]
[12] Dixon, S.J., Winter, G.E., Musavi, L.S., Lee, E.D., Snijder, B., Rebsamen, M., et al. (2015) Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death. ACS Chemical Biology, 10, 1604-1609. [Google Scholar] [CrossRef] [PubMed]
[13] Zou, Y., Palte, M.J., Deik, A.A., Li, H., Eaton, J.K., Wang, W., et al. (2019) A GPX4-Dependent Cancer Cell State Underlies the Clear-Cell Morphology and Confers Sensitivity to Ferroptosis. Nature Communications, 10, Article No. 1617. [Google Scholar] [CrossRef] [PubMed]
[14] Liao, P., Wang, W., Wang, W., Kryczek, I., Li, X., Bian, Y., et al. (2022) CD8+ T Cells and Fatty Acids Orchestrate Tumor Ferroptosis and Immunity via ACSL4. Cancer Cell, 40, 365-378.e6. [Google Scholar] [CrossRef] [PubMed]
[15] Yang, Y., Zhu, T., Wang, X., Xiong, F., Hu, Z., Qiao, X., et al. (2022) ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers. Cancers, 14, Article No. 5896. [Google Scholar] [CrossRef] [PubMed]
[16] Brown, C.W., Amante, J.J., Goel, H.L. and Mercurio, A.M. (2017) The Α6β4 Integrin Promotes Resistance to Ferroptosis. Journal of Cell Biology, 216, 4287-4297. [Google Scholar] [CrossRef] [PubMed]
[17] Wu, J., Minikes, A.M., Gao, M., Bian, H., Li, Y., Stockwell, B.R., et al. (2019) Intercellular Interaction Dictates Cancer Cell Ferroptosis via NF2-YAP Signalling. Nature, 572, 402-406. [Google Scholar] [CrossRef] [PubMed]
[18] Li, Y., Feng, D., Wang, Z., Zhao, Y., Sun, R., Tian, D., et al. (2019) Ischemia-Induced ACSL4 Activation Contributes to Ferroptosis-Mediated Tissue Injury in Intestinal Ischemia/Reperfusion. Cell Death & Differentiation, 26, 2284-2299. [Google Scholar] [CrossRef] [PubMed]
[19] Lei, G., Zhang, Y., Koppula, P., Liu, X., Zhang, J., Lin, S.H., et al. (2020) The Role of Ferroptosis in Ionizing Radiation-Induced Cell Death and Tumor Suppression. Cell Research, 30, 146-162. [Google Scholar] [CrossRef] [PubMed]
[20] Reeves, A.R., Sansbury, B.E., Pan, M., Han, X., Spite, M. and Greenberg, A.S. (2021) Myeloid-Specific Deficiency of Long-Chain Acyl Coa Synthetase 4 Reduces Inflammation by Remodeling Phospholipids and Reducing Production of Arachidonic Acid-Derived Proinflammatory Lipid Mediators. The Journal of Immunology, 207, 2744-2753. [Google Scholar] [CrossRef] [PubMed]
[21] Zhang, J., Liu, Y., Li, Q., Zuo, L., Zhang, B., Zhao, F., et al. (2023) ACSL4: A Double-Edged Sword Target in Multiple Myeloma, Promotes Cell Proliferation and Sensitizes Cell to Ferroptosis. Carcinogenesis, 44, 242-251. [Google Scholar] [CrossRef] [PubMed]
[22] Miao, Z., Tian, W., Ye, Y., Gu, W., Bao, Z., Xu, L., et al. (2022) Hsp90 Induces Acsl4-Dependent Glioma Ferroptosis via Dephosphorylating Ser637 at Drp1. Cell Death & Disease, 13, Article No. 548. [Google Scholar] [CrossRef] [PubMed]
[23] Liu, H., Xue, H., Guo, Q., Xue, X., Yang, L., Zhao, K., et al. (2025) Ferroptosis Meets Inflammation: A New Frontier in Cancer Therapy. Cancer Letters, 620, Article ID: 217696. [Google Scholar] [CrossRef] [PubMed]
[24] Liu, J., Zhang, C., Wang, J., Hu, W. and Feng, Z. (2020) The Regulation of Ferroptosis by Tumor Suppressor p53 and Its Pathway. International Journal of Molecular Sciences, 21, Article No. 8387. [Google Scholar] [CrossRef] [PubMed]
[25] Jiang, X., Stockwell, B.R. and Conrad, M. (2021) Ferroptosis: Mechanisms, Biology and Role in Disease. Nature Reviews Molecular Cell Biology, 22, 266-282. [Google Scholar] [CrossRef] [PubMed]
[26] Gao, M., Monian, P., Quadri, N., Ramasamy, R. and Jiang, X. (2015) Glutaminolysis and Transferrin Regulate Ferroptosis. Molecular Cell, 59, 298-308. [Google Scholar] [CrossRef] [PubMed]
[27] Yang, C., Ko, B., Hensley, C.T., Jiang, L., Wasti, A.T., Kim, J., et al. (2014) Glutamine Oxidation Maintains the TCA Cycle and Cell Survival during Impaired Mitochondrial Pyruvate Transport. Molecular Cell, 56, 414-424. [Google Scholar] [CrossRef] [PubMed]
[28] Hu, W., Zhang, C., Wu, R., Sun, Y., Levine, A. and Feng, Z. (2010) Glutaminase 2, a Novel P53 Target Gene Regulating Energy Metabolism and Antioxidant Function. Proceedings of the National Academy of Sciences, 107, 7455-7460. [Google Scholar] [CrossRef] [PubMed]
[29] Araujo, L., Khim, P., Mkhikian, H., Mortales, C. and Demetriou, M. (2017) Glycolysis and Glutaminolysis Cooperatively Control T Cell Function by Limiting Metabolite Supply to N-Glycosylation. eLife, 6, e21330. [Google Scholar] [CrossRef] [PubMed]
[30] LaMonte, G., Tang, X., Chen, J.L., Wu, J., Ding, C.C., Keenan, M.M., et al. (2013) Acidosis Induces Reprogramming of Cellular Metabolism to Mitigate Oxidative Stress. Cancer & Metabolism, 1, Article No. 23. [Google Scholar] [CrossRef] [PubMed]
[31] Yang, L., Venneti, S. and Nagrath, D. (2017) Glutaminolysis: A Hallmark of Cancer Metabolism. Annual Review of Biomedical Engineering, 19, 163-194. [Google Scholar] [CrossRef] [PubMed]
[32] Suzuki, S., Venkatesh, D., Kanda, H., Nakayama, A., Hosokawa, H., Lee, E., et al. (2022) GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma. Cancer Research, 82, 3209-3222. [Google Scholar] [CrossRef] [PubMed]
[33] Wang, Y., Zheng, L., Shang, W., Yang, Z., Li, T., Liu, F., et al. (2022) Wnt/Beta-Catenin Signaling Confers Ferroptosis Resistance by Targeting GPX4 in Gastric Cancer. Cell Death & Differentiation, 29, 2190-2202. [Google Scholar] [CrossRef] [PubMed]
[34] He, Q., Chen, N., Wang, X., Li, P., Liu, L., Rong, Z., et al. (2023) Prognostic Value and Immunological Roles of GPX3 in Gastric Cancer. International Journal of Medical Sciences, 20, 1399-1416. [Google Scholar] [CrossRef] [PubMed]
[35] Doll, S., Freitas, F.P., Shah, R., Aldrovandi, M., da Silva, M.C., Ingold, I., et al. (2019) FSP1 Is a Glutathione-Independent Ferroptosis Suppressor. Nature, 575, 693-698. [Google Scholar] [CrossRef] [PubMed]
[36] Bersuker, K., Hendricks, J.M., Li, Z., Magtanong, L., Ford, B., Tang, P.H., et al. (2019) The Coq Oxidoreductase FSP1 Acts Parallel to GPX4 to Inhibit Ferroptosis. Nature, 575, 688-692. [Google Scholar] [CrossRef] [PubMed]
[37] Soula, M., Weber, R.A., Zilka, O., Alwaseem, H., La, K., Yen, F., et al. (2020) Metabolic Determinants of Cancer Cell Sensitivity to Canonical Ferroptosis Inducers. Nature Chemical Biology, 16, 1351-1360. [Google Scholar] [CrossRef] [PubMed]
[38] Barayeu, U., Schilling, D., Eid, M., Xavier da Silva, T.N., Schlicker, L., Mitreska, N., et al. (2022) Hydropersulfides Inhibit Lipid Peroxidation and Ferroptosis by Scavenging Radicals. Nature Chemical Biology, 19, 28-37. [Google Scholar] [CrossRef] [PubMed]
[39] Lee, H., Zandkarimi, F., Zhang, Y., Meena, J.K., Kim, J., Zhuang, L., et al. (2020) Energy-Stress-Mediated AMPK Activation Inhibits Ferroptosis. Nature Cell Biology, 22, 225-234. [Google Scholar] [CrossRef] [PubMed]
[40] Li, C., Dong, X., Du, W., Shi, X., Chen, K., Zhang, W., et al. (2020) LKB1-AMPK Axis Negatively Regulates Ferroptosis by Inhibiting Fatty Acid Synthesis. Signal Transduction and Targeted Therapy, 5, Article No. 187. [Google Scholar] [CrossRef] [PubMed]
[41] Zhao, Y., Li, M., Yao, X., Fei, Y., Lin, Z., Li, Z., et al. (2020) HCAR1/MCT1 Regulates Tumor Ferroptosis through the Lactate-Mediated AMPK-SCD1 Activity and Its Therapeutic Implications. Cell Reports, 33, Article ID: 108487. [Google Scholar] [CrossRef] [PubMed]
[42] Zhao, L., Zhou, X., Xie, F., Zhang, L., Yan, H., Huang, J., et al. (2022) Ferroptosis in Cancer and Cancer Immunotherapy. Cancer Communications, 42, 88-116. [Google Scholar] [CrossRef] [PubMed]
[43] Ma, P., Xiao, H., Yu, C., Liu, J., Cheng, Z., Song, H., et al. (2017) Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species. Nano Letters, 17, 928-937. [Google Scholar] [CrossRef] [PubMed]
[44] Chow, E.K. and Ho, D. (2013) Cancer Nanomedicine: From Drug Delivery to Imaging. Science Translational Medicine, 5, 216rv214. [Google Scholar] [CrossRef] [PubMed]
[45] An, Y., Zhu, J., Liu, F., Deng, J., Meng, X., Liu, G., et al. (2019) Boosting the Ferroptotic Antitumor Efficacy via Site-Specific Amplification of Tailored Lipid Peroxidation. ACS Applied Materials & Interfaces, 11, 29655-29666. [Google Scholar] [CrossRef] [PubMed]
[46] Wang, X., Hua, P., He, C. and Chen, M. (2022) Non-Apoptotic Cell Death-Based Cancer Therapy: Molecular Mechanism, Pharmacological Modulators, and Nanomedicine. Acta Pharmaceutica Sinica B, 12, 3567-3593. [Google Scholar] [CrossRef] [PubMed]
[47] Gasparri, M.L., Besharat, Z.M., Farooqi, A.A., Khalid, S., Taghavi, K., Besharat, R.A., et al. (2018) MiRNAs and Their Interplay with PI3K/AKT/mTOR Pathway in Ovarian Cancer Cells: A Potential Role in Platinum Resistance. Journal of Cancer Research and Clinical Oncology, 144, 2313-2318. [Google Scholar] [CrossRef] [PubMed]
[48] Wiczling, P., Daghir-Wojtkowiak, E., Kaliszan, R., Markuszewski, M.J., Limon, J., Koczkowska, M., et al. (2019) Bayesian Multilevel Model of MicroRNA Levels in Ovarian-Cancer and Healthy Subjects. PLOS ONE, 14, e0221764. [Google Scholar] [CrossRef] [PubMed]
[49] Mei, Y., Jiang, P., Shen, N., Fu, S. and Zhang, J. (2020) Identification of miRNA-mRNA Regulatory Network and Construction of Prognostic Signature in Cervical Cancer. DNA and Cell Biology, 39, 1023-1040. [Google Scholar] [CrossRef] [PubMed]
[50] Chen, X. and Zhang, N. (2018) Downregulation of lncRNA NEAT12 Radiosensitizes Hepatocellular Carcinoma Cells through Regulation of miR-101-3p/WEE1 Axis. Cell Biology International, 43, 44-55. [Google Scholar] [CrossRef] [PubMed]
[51] Luan, C., Li, Y., Liu, Z. and Zhao, C. (2020) Long Noncoding RNA MALAT1 Promotes the Development of Colon Cancer by Regulating miR-101-3p/STC1 Axis. OncoTargets and Therapy, 13, 3653-3665. [Google Scholar] [CrossRef] [PubMed]
[52] Li, K., Jiang, Y., Xiang, X., Gong, Q., Zhou, C., Zhang, L., et al. (2020) Long Non‐Coding RNA SNHG6 Promotes the Growth and Invasion of Non‐Small Cell Lung Cancer by Downregulating miR-101-3p. Thoracic Cancer, 11, 1180-1190. [Google Scholar] [CrossRef] [PubMed]
[53] Luo, Y., Niu, G., Yi, H., Li, Q., Wu, Z., Wang, J., et al. (2021) Nanomedicine Promotes Ferroptosis to Inhibit Tumour Proliferation in Vivo. Redox Biology, 42, Article ID: 101908. [Google Scholar] [CrossRef] [PubMed]
[54] Chen, Q., Espey, M.G., Krishna, M.C., Mitchell, J.B., Corpe, C.P., Buettner, G.R., et al. (2005) Pharmacologic Ascorbic Acid Concentrations Selectively Kill Cancer Cells: Action as a Pro-Drug to Deliver Hydrogen Peroxide to Tissues. Proceedings of the National Academy of Sciences, 102, 13604-13609. [Google Scholar] [CrossRef] [PubMed]
[55] Xiao, H., Du, M., Sun, X., Xu, R., Li, D., Yue, S., et al. (2024) A Highly Biocompatible Polyoxotungstate with Fenton‐Like Reaction Activity for Potent Chemodynamic Therapy of Tumors. Angewandte Chemie International Edition, 64, e202422949. [Google Scholar] [CrossRef] [PubMed]
[56] Xi, S., Yang, Y., Suo, J. and Sun, T. (2022) Research Progress on Gene Editing Based on Nano-Drug Delivery Vectors for Tumor Therapy. Frontiers in Bioengineering and Biotechnology, 10, Article ID: 873369. [Google Scholar] [CrossRef] [PubMed]
[57] Park, E. and Chung, S.W. (2019) ROS-Mediated Autophagy Increases Intracellular Iron Levels and Ferroptosis by Ferritin and Transferrin Receptor Regulation. Cell Death & Disease, 10, Article No. 822. [Google Scholar] [CrossRef] [PubMed]
[58] Gao, M., Monian, P., Pan, Q., Zhang, W., Xiang, J. and Jiang, X. (2016) Ferroptosis Is an Autophagic Cell Death Process. Cell Research, 26, 1021-1032. [Google Scholar] [CrossRef] [PubMed]
[59] Hou, W., Xie, Y., Song, X., Sun, X., Lotze, M.T., Zeh, H.J., et al. (2016) Autophagy Promotes Ferroptosis by Degradation of Ferritin. Autophagy, 12, 1425-1428. [Google Scholar] [CrossRef] [PubMed]
[60] Liu, X., Zhao, P., Wang, X., Wang, L., Zhu, Y., Song, Y., et al. (2019) Celastrol Mediates Autophagy and Apoptosis via the ROS/JNK and Akt/mTOR Signaling Pathways in Glioma Cells. Journal of Experimental & Clinical Cancer Research, 38, Article No. 184. [Google Scholar] [CrossRef] [PubMed]
[61] Fu, H., Wang, C., Yang, D., Wei, Z., Xu, J., Hu, Z., et al. (2018) Curcumin Regulates Proliferation, Autophagy, and Apoptosis in Gastric Cancer Cells by Affecting PI3K and P53 Signaling. Journal of Cellular Physiology, 233, 4634-4642. [Google Scholar] [CrossRef] [PubMed]
[62] Wei, S., Qiu, T., Yao, X., Wang, N., Jiang, L., Jia, X., et al. (2020) Arsenic Induces Pancreatic Dysfunction and Ferroptosis via Mitochondrial ROS-Autophagy-Lysosomal Pathway. Journal of Hazardous Materials, 384, Article ID: 121390. [Google Scholar] [CrossRef] [PubMed]
[63] Andreani, C., Bartolacci, C. and Scaglioni, P.P. (2022) Ferroptosis: A Specific Vulnerability of RAS-Driven Cancers? Frontiers in Oncology, 12, Article ID: 923915. [Google Scholar] [CrossRef] [PubMed]
[64] Lee, N., Carlisle, A.E., Peppers, A., Park, S.J., Doshi, M.B., Spears, M.E., et al. (2021) xCT-Driven Expression of GPX4 Determines Sensitivity of Breast Cancer Cells to Ferroptosis Inducers. Antioxidants, 10, Article No. 317. [Google Scholar] [CrossRef] [PubMed]
[65] Ye, F., Chai, W., Xie, M., Yang, M., Yu, Y., Cao, L., et al. (2019) HMGB1 Regulates Erastin-Induced Ferroptosis via RAS-JNK/p38 Signaling in HL-60/NRAS (Q61L) Cells. American Journal of Cancer Research, 9, 730-739.
[66] Chen, X., Kang, R., Kroemer, G. and Tang, D. (2021) Organelle-Specific Regulation of Ferroptosis. Cell Death & Differentiation, 28, 2843-2856. [Google Scholar] [CrossRef] [PubMed]
[67] Li, Y., Ran, Q., Duan, Q., Jin, J., Wang, Y., Yu, L., et al. (2024) 7-Dehydrocholesterol Dictates Ferroptosis Sensitivity. Nature, 626, 411-418. [Google Scholar] [CrossRef] [PubMed]
[68] Wang, H., Wang, C., Li, B., Zheng, C., Liu, G., Liu, Z., et al. (2023) Discovery of Ml210-Based Glutathione Peroxidase 4 (GPX4) Degrader Inducing Ferroptosis of Human Cancer Cells. European Journal of Medicinal Chemistry, 254, Article ID: 115343. [Google Scholar] [CrossRef] [PubMed]
[69] Cheff, D.M., Huang, C., Scholzen, K.C., Gencheva, R., Ronzetti, M.H., Cheng, Q., et al. (2023) The Ferroptosis Inducing Compounds RSL3 and ML162 Are Not Direct Inhibitors of GPX4 but of TXNRD1. Redox Biology, 62, Article ID: 102703. [Google Scholar] [CrossRef] [PubMed]
[70] Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Skouta, R., Zaitsev, E.M., Gleason, C.E., et al. (2012) Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death. Cell, 149, 1060-1072. [Google Scholar] [CrossRef] [PubMed]
[71] Stockwell, B.R., Friedmann Angeli, J.P., Bayir, H., Bush, A.I., Conrad, M., Dixon, S.J., et al. (2017) Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell, 171, 273-285. [Google Scholar] [CrossRef] [PubMed]
[72] McBean, G.J. (2011) The Transsulfuration Pathway: A Source of Cysteine for Glutathione in Astrocytes. Amino Acids, 42, 199-205. [Google Scholar] [CrossRef] [PubMed]
[73] Yang, W.S., SriRamaratnam, R., Welsch, M.E., Shimada, K., Skouta, R., Viswanathan, V.S., et al. (2014) Regulation of Ferroptotic Cancer Cell Death by Gpx4. Cell, 156, 317-331. [Google Scholar] [CrossRef] [PubMed]
[74] Shimada, K., Hayano, M., Pagano, N.C. and Stockwell, B.R. (2016) Cell-Line Selectivity Improves the Predictive Power of Pharmacogenomic Analyses and Helps Identify NADPH as Biomarker for Ferroptosis Sensitivity. Cell Chemical Biology, 23, 225-235. [Google Scholar] [CrossRef] [PubMed]